Characterization and risk factors of hyperglycaemia during treatment of childhood hematologic malignancies.
Sophie WelschKiswendsida SawadogoBénédicte BrichardMaelle de Ville de GoyetAn Van DammeCécile BoulangerPhilippe A LysyPublished in: Diabetic medicine : a journal of the British Diabetic Association (2021)
In our cohort, 18% of patients with ALL or NHL developed early-onset hyperglycaemia after chemotherapy/radiotherapy. Patients with ALL with increased hyperglycaemia risk can be readily identified by measuring BMI and puberty stage at cancer diagnosis. Also, glucose monitoring should be reinforced when patients show steroid-resistant disease and/or require HSCT.
Keyphrases
- early onset
- risk factors
- end stage renal disease
- late onset
- ejection fraction
- newly diagnosed
- chronic kidney disease
- locally advanced
- body mass index
- early stage
- prognostic factors
- radiation therapy
- papillary thyroid
- radiation induced
- patient reported outcomes
- squamous cell
- physical activity
- weight loss
- patient reported
- early life